1 Min Read
Sept 6 (Reuters) - Progenics Pharmaceuticals Inc
* Valeant and Progenics announce the U.S. commercial launch of FDA approved Relistor tablets Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.